Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 130 articles: HTML format

Single Articles

September 2022
1. GRAHAM RM
   Adverse events after spontaneous coronary artery dissection.
   Heart. 2022;108:1506-1507.
   PubMed    
   
   
   
2. GARCIA-GUIMARAES M, Masotti M, Sanz-Ruiz R, Macaya F, et al
   Clinical outcomes in spontaneous coronary artery dissection.
   Heart. 2022;108:1530-1538.
   PubMed     Abstract available
   
   
   August 2022
3. SILVERIO A, Parodi G, Scudiero F, Bossone E, et al
   Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome.
   Heart. 2022;108:1369-1376.
   PubMed     Abstract available
   
   
   
4. ROOS A, Edgren G
   Using historical cardiac troponins to identify patients at a high risk of myocardial infarction.
   Heart. 2022 Aug 10. pii: heartjnl-2022-321198. doi: 10.1136/heartjnl-2022-321198
   PubMed     Abstract available
   
   
   July 2022
5. OTTO CM
   Heartbeat: long-term outcomes in patients with symptomatic coronary artery spasm.
   Heart. 2022;108:1247-1249.
   PubMed    
   
   
   June 2022
6. OTTO CM
   Heartbeat: treatment delays with telephone triage for acute myocardial infarction.
   Heart. 2022;108:1075-1077.
   PubMed    
   
   
   May 2022
7. BHASIN D, Kumar R, Bansal S
   Man with recent myocardial infarction and heart failure.
   Heart. 2022;108:847-898.
   PubMed    
   
   
   
8. VILLINES TC, Weber LA
   Trust us! Time to move on from pretest probability scores for stable chest pain.
   Heart. 2022;108:822-823.
   PubMed    
   
   
   
9. FORDYCE CB, Hill CL, Mark DB, Alhanti B, et al
   Physician judgement in predicting obstructive coronary artery disease and adverse events in chest pain patients.
   Heart. 2022;108:860-867.
   PubMed     Abstract available
   
   
   
10. AL-LAMEE R, Aubiniere-Robb L, Berry C
    The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond.
    Heart. 2022;108:800-806.
    PubMed     Abstract available
    
    
    April 2022
11. MCDERMOTT M, Bing R
    Coronary vasospasm and future percutaneous coronary intervention: relax.
    Heart. 2022 Apr 12. pii: heartjnl-2022-320974. doi: 10.1136/heartjnl-2022-320974
    PubMed    
    
    
    
12. SANZ-SANCHEZ J, Stefanini GG
    Timing and completeness of revascularisation in acute coronary syndromes.
    Heart. 2022;108:648-656.
    PubMed    
    
    
    
13. ORTEGA-LEGASPI JM, Bravo PE
    Diagnosis and management of cardiac allograft vasculopathy.
    Heart. 2022;108:586-592.
    PubMed     Abstract available
    
    
    
14. KITE TA, Ladwiniec A, Arnold JR, McCann GP, et al
    Early invasive versus non-invasive assessment in patients with suspected non-ST-elevation acute coronary syndrome.
    Heart. 2022;108:500-506.
    PubMed     Abstract available
    
    
    March 2022
15. SZE S, Ayton SL, Moss AJ
    Should we always call 911/999 to get it right first time in suspected myocardial infarction?
    Heart. 2022 Mar 31. pii: heartjnl-2022-320918. doi: 10.1136/heartjnl-2022-320918
    PubMed    
    
    
    
16. HODGINS P, McMinn M, Shah A, Reed MJ, et al
    Unscheduled care pathways in patients with myocardial infarction in Scotland.
    Heart. 2022 Mar 31. pii: heartjnl-2021-320614. doi: 10.1136/heartjnl-2021-320614
    PubMed     Abstract available
    
    
    
17. KIM JH, Park J, Yang Y, Lee S, et al
    Percutaneous coronary intervention in patients with documented coronary vasospasm during long-term follow-up.
    Heart. 2022 Mar 22. pii: heartjnl-2021-320645. doi: 10.1136/heartjnl-2021-320645
    PubMed     Abstract available
    
    
    
18. KELION A, Sabharwal N, Holdsworth D, Dawkins S, et al
    Clinical and economic impact of extracardiac lesions on coronary CT angiography.
    Heart. 2022 Mar 22. pii: heartjnl-2021-320698. doi: 10.1136/heartjnl-2021-320698
    PubMed     Abstract available
    
    
    
19. BHASIN D, Kumar R, Gupta A
    Man with recent inferior wall myocardial infarction.
    Heart. 2022;108:428-492.
    PubMed    
    
    
    
20. OTTO CM
    Heartbeat: delayed and inadequate treatment of acute coronary syndromes during the COVID-19 pandemic.
    Heart. 2022;108:407-409.
    PubMed    
    
    
    
21. CAMMANN VL, Templin C
    The STEMI phenomenon during the COVID-19 pandemic: what is beneath the tip of the iceberg?
    Heart. 2022;108:412-413.
    PubMed    
    
    
    
22. FABRIS E, Sinagra G
    Physical activity in older people: better late than never, but better early than late.
    Heart. 2022;108:328-329.
    PubMed    
    
    
    February 2022
23. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available
    
    
    
24. IOANNOU A
    Unusual presentation of cardiogenic shock in a young patient.
    Heart. 2022;108:211-242.
    PubMed    
    
    
    
25. LEVY M, Chen Y, Clarke R, Guo Y, et al
    Gender differences in use of invasive diagnostic and therapeutic procedures for acute ischaemic heart disease in Chinese adults.
    Heart. 2022;108:292-299.
    PubMed     Abstract available
    
    
    
26. BESKA B, Coakley D, MacGowan G, Adams-Hall J, et al
    Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome.
    Heart. 2022;108:203-211.
    PubMed     Abstract available
    
    
    January 2022
27. CHANNON KM, Newby DE, Nicol ED, Deanfield J, et al
    Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat.
    Heart. 2022 Jan 12. pii: heartjnl-2021-320265. doi: 10.1136/heartjnl-2021-320265
    PubMed     Abstract available
    
    
    
28. CIMCI M, Polad J, Mamas M, Iniguez-Romo A, et al
    Outcomes and regional differences in practice in a worldwide coronary stent registry.
    Heart. 2022 Jan 10. pii: heartjnl-2021-320116. doi: 10.1136/heartjnl-2021-320116
    PubMed     Abstract available
    
    
    
29. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    PubMed    
    
    
    
30. AGCA R, Smulders Y, Nurmohamed M
    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice.
    Heart. 2022;108:73-79.
    PubMed    
    
    
    November 2021
31. MULLER D, Glarner N, Lopez-Ayala P, Puelacher C, et al
    Correspondence on "Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery" by Park et al.
    Heart. 2021 Nov 26. pii: heartjnl-2021-320436. doi: 10.1136/heartjnl-2021-320436
    PubMed    
    
    
    
32. SIEGERSMA KR, Onland-Moret NC, Appelman Y, van der Harst P, et al
    Outcomes in patients with a first episode of chest pain undergoing early coronary CT imaging.
    Heart. 2021 Nov 15. pii: heartjnl-2021-319747. doi: 10.1136/heartjnl-2021-319747
    PubMed     Abstract available
    
    
    
33. RAQABANI MA, Musa AM, Al-Assaf OY
    ST elevation in a critically ill patient with COVID-19: what is the emergency treatment?
    Heart. 2021;107:1703-1764.
    PubMed    
    
    
    
34. SUNG KC, Hong YS, Lee JY, Lee SJ, et al
    Physical activity and the progression of coronary artery calcification.
    Heart. 2021;107:1710-1716.
    PubMed     Abstract available
    
    
    
35. GULSIN GS, Moss AJ
    Coronary artery calcium paradox and physical activity.
    Heart. 2021;107:1686-1687.
    PubMed    
    
    
    October 2021
36. DE LUCA G, Algowhary M, Uguz B, Oliveira DC, et al
    COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.
    Heart. 2021 Oct 28. pii: heartjnl-2021-319750. doi: 10.1136/heartjnl-2021-319750
    PubMed     Abstract available
    
    
    
37. NORGAARD BL, Gaur S, Fairbairn TA, Douglas PS, et al
    Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319773. doi: 10.1136/heartjnl-2021-319773
    PubMed     Abstract available
    
    
    
38. CHAN DZL, Kerr A, Grey C, Selak V, et al
    Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006-2018.
    Heart. 2021 Oct 22. pii: heartjnl-2021-319853. doi: 10.1136/heartjnl-2021-319853
    PubMed     Abstract available
    
    
    
39. ASLEH R
    Persistent sex differences in outcomes after coronary heart disease: time to move from observation to action.
    Heart. 2021 Oct 19. pii: heartjnl-2021-320031. doi: 10.1136/heartjnl-2021-320031
    PubMed    
    
    
    
40. DE ABAJO FJ, Rodriguez-Martin S, Barreira D, Rodriguez-Miguel A, et al
    Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319754. doi: 10.1136/heartjnl-2021-319754
    PubMed     Abstract available
    
    
    
41. TIJSSEN A, Snaterse M, Minneboo M, Lachman S, et al
    Weight management and determinants of weight change in patients with coronary artery disease.
    Heart. 2021;107:1552-1559.
    PubMed     Abstract available
    
    
    September 2021
42. COELHO-LIMA J, Georgiopoulos G, Ahmed J, Adil SER, et al
    Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
    Heart. 2021 Sep 20. pii: heartjnl-2021-319225. doi: 10.1136/heartjnl-2021-319225
    PubMed     Abstract available
    
    
    
43. MCLEOD P, Adamson PD, Coffey S
    Do we need early risk stratification after ST-elevation myocardial infarction?
    Heart. 2021 Sep 20. pii: heartjnl-2021-320030. doi: 10.1136/heartjnl-2021-320030
    PubMed    
    
    
    
44. LIU Y, Tan N, Huo Y, Chen S, et al
    Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
    Heart. 2021 Sep 11. pii: heartjnl-2021-319716. doi: 10.1136/heartjnl-2021-319716
    PubMed     Abstract available
    
    
    
45. LOWRY MTH, Anand A, Mills NL
    Implementing an early rule-out pathway for acute myocardial infarction in clinical practice.
    Heart. 2021 Sep 3. pii: heartjnl-2019-316242. doi: 10.1136/heartjnl-2019-316242.
    PubMed    
    
    
    
46. OTTO CM
    Heartbeat: Intervention for spontaneous coronary artery dissection?
    Heart. 2021;107:1357-1359.
    PubMed    
    
    
    
47. GERMAN CA, Shapiro MD
    Roadmap to a career in preventive cardiology.
    Heart. 2021;107:1435-1436.
    PubMed    
    
    
    
48. ADAMSON PD
    Spontaneous coronary artery dissection: to do good or to do no harm?
    Heart. 2021;107:1362-1363.
    PubMed    
    
    
    
49. BARBATO E
    Contemporary management of calcified coronary lesions.
    Heart. 2021;107:1510-1517.
    PubMed    
    
    
    
50. SINGH T, Chapman AR, Dweck MR, Mills NL, et al
    MINOCA: a heterogenous group of conditions associated with myocardial damage.
    Heart. 2021;107:1458-1464.
    PubMed     Abstract available
    
    
    August 2021
51. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available
    
    
    
52. BAINEY KR, Zheng Y, Coulden R, Sonnex E, et al
    Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial.
    Heart. 2021 Aug 20. pii: heartjnl-2021-319455. doi: 10.1136/heartjnl-2021-319455
    PubMed     Abstract available
    
    
    July 2021
53. MASSERA D, Hu M, Delaney JA, Bartz TM, et al
    Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study.
    Heart. 2021 Jul 13. pii: heartjnl-2021-319296. doi: 10.1136/heartjnl-2021-319296
    PubMed     Abstract available
    
    
    
54. DARMON A, Ducrocq G
    Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge.
    Heart. 2021;107:1109-1110.
    PubMed    
    
    
    
55. ALMARZOOQ ZI, Colantonio LD, Okin PM, Richman JS, et al
    Risk for cardiovascular events following 'microsize' versus usual myocardial infarctions.
    Heart. 2021;107:1152-1159.
    PubMed     Abstract available
    
    
    June 2021
56. PHREANER N, Daniels LB
    Sex differences in type 2 myocardial infarction: learning that we still have a lot to learn.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319432. doi: 10.1136/heartjnl-2021-319432
    PubMed    
    
    
    
57. LEEDY D, Tiwana JK, Mamas M, Hira R, et al
    Coronary revascularisation outcomes in patients with cancer.
    Heart. 2021 Jun 15. pii: heartjnl-2020-318531. doi: 10.1136/heartjnl-2020-318531
    PubMed     Abstract available
    
    
    
58. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    PubMed    
    
    
    
59. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    PubMed     Abstract available
    
    
    May 2021
60. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available
    
    
    
61. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    PubMed     Abstract available
    
    
    
62. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available
    
    
    
63. KOTECHA D, Garcia-Guimaraes M, Premawardhana D, Pellegrini D, et al
    Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection.
    Heart. 2021 May 18. pii: heartjnl-2020-318914. doi: 10.1136/heartjnl-2020-318914
    PubMed     Abstract available
    
    
    
64. CHUA A, Adams D, Dey D, Blankstein R, et al
    Coronary artery disease in East and South Asians: differences observed on cardiac CT.
    Heart. 2021 May 13. pii: heartjnl-2020-318929. doi: 10.1136/heartjnl-2020-318929
    PubMed     Abstract available
    
    
    
65. CADER FA, Yancy CW, Banerjee S
    To be, or not to be BAME, in the time of COVID-19: does it matter?
    Heart. 2021;107:692-693.
    PubMed    
    
    
    
66. BODY R
    Trial is error? Evaluating the effectiveness of single-troponin diagnostic pathways.
    Heart. 2021;107:690-691.
    PubMed    
    
    
    
67. BARNES C, Fatovich DM, Macdonald SPJ, Alcock RF, et al
    Single high-sensitivity troponin levels to assess patients with potential acute coronary syndromes.
    Heart. 2021;107:721-727.
    PubMed     Abstract available
    
    
    
68. PECK KY, Andrianopoulos N, Dinh D, Roberts L, et al
    Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome.
    Heart. 2021;107:728-733.
    PubMed     Abstract available
    
    
    April 2021
69. KIMENAI DM, Lindahl B, Chapman AR, Baron T, et al
    Sex differences in investigations and outcomes among patients with type 2 myocardial infarction.
    Heart. 2021 Apr 20. pii: heartjnl-2021-319118. doi: 10.1136/heartjnl-2021-319118
    PubMed     Abstract available
    
    
    
70. MCGOVERN L, Cosgrave J
    Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318226. doi: 10.1136/heartjnl-2020-318226.
    PubMed     Abstract available
    
    
    
71. ZHANG KW
    Out of the woods, but still in the weeds: When cancer therapy becomes part of a chronic condition.
    Heart. 2021;107:607-608.
    PubMed    
    
    
    March 2021
72. STOREY RF
    Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
    Heart. 2021 Mar 19. pii: heartjnl-2020-318872. doi: 10.1136/heartjnl-2020-318872
    PubMed    
    
    
    
73. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available
    
    
    
74. RASHID M, Timmis A, Kinnaird T, Curzen N, et al
    Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic.
    Heart. 2021 Mar 8. pii: heartjnl-2020-318356. doi: 10.1136/heartjnl-2020-318356.
    PubMed     Abstract available
    
    
    
75. SIMON T, Danchin N
    Beware of simple explanations.
    Heart. 2021;107:348-349.
    PubMed    
    
    
    
76. KUMAR R, Bhasin D, Isser HS
    Typical chest pain and an ominous ECG.
    Heart. 2021;107:380-432.
    PubMed    
    
    
    February 2021
77. DANCHIN N, Marijon E
    COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether?
    Heart. 2021 Feb 1. pii: heartjnl-2020-318646. doi: 10.1136/heartjnl-2020-318646.
    PubMed    
    
    
    January 2021
78. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available
    
    
    
79. GIANNOPOULOS G, Karageorgiou S, Vrachatis D, Anagnostopoulos I, et al
    A stand-alone structured educational programme after myocardial infarction: a randomised study.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318414. doi: 10.1136/heartjnl-2020-318414
    PubMed     Abstract available
    
    
    
80. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    PubMed     Abstract available
    
    
    
81. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available
    
    
    
82. RYAN M, Morgan H, Petrie MC, Perera D, et al
    Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Heart. 2021 Jan 12. pii: heartjnl-2020-316856. doi: 10.1136/heartjnl-2020-316856
    PubMed     Abstract available
    
    
    
83. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available
    
    
    
84. GHOBRIAL M, Haley HA, Gosling R, Rammohan V, et al
    The new role of diagnostic angiography in coronary physiological assessment.
    Heart. 2021 Jan 8. pii: heartjnl-2020-318289. doi: 10.1136/heartjnl-2020-318289.
    PubMed     Abstract available
    
    
    
85. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available
    
    
    
86. KOK WE
    Too often and too early: the risk of cardiac ischaemia in adult survivors of childhood cancer.
    Heart. 2021;107:6-7.
    PubMed    
    
    
    
87. ONISHI T, Nakano Y, Hirano KI, Nagasawa Y, et al
    Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.
    Heart. 2021;107:127-134.
    PubMed     Abstract available
    
    
    
88. FEIJEN EAM, van Dalen EC, van der Pal HJH, Reulen RC, et al
    Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study.
    Heart. 2021;107:33-40.
    PubMed     Abstract available
    
    
    
89. JOLICOEUR EM, Verheye S, Henry TD, Joseph L, et al
    A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Heart. 2021;107:41-46.
    PubMed     Abstract available
    
    
    December 2020
90. DE FILIPPO O, D'Ascenzo F, Deferrari GM
    COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
    Heart. 2020;106:1786-1787.
    PubMed    
    
    
    November 2020
91. MINTZ GS, Ali Z, Maehara A
    Use of intracoronary imaging to guide optimal percutaneous coronary intervention procedures and outcomes.
    Heart. 2020 Nov 30. pii: heartjnl-2020-316745. doi: 10.1136/heartjnl-2020-316745
    PubMed    
    
    
    
92. OTTO CM
    Heartbeat: exercise improves quality of life after acute myocardial infarction.
    Heart. 2020;106:1705-1706.
    PubMed    
    
    
    October 2020
93. DING Q, Spatz ES, Lipska KJ, Lin H, et al
    Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults.
    Heart. 2020 Oct 20. pii: heartjnl-2020-317101. doi: 10.1136/heartjnl-2020-317101
    PubMed     Abstract available
    
    
    
94. DE BACQUER D, van de Luitgaarden IAT, De Smedt D, Vynckier P, et al
    Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317549. doi: 10.1136/heartjnl-2020-317549
    PubMed     Abstract available
    
    
    
95. MOHAMMAD MA, Koul S, Olivecrona GK, Gtberg M, et al
    Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
    Heart. 2020 Oct 6. pii: heartjnl-2020-317685. doi: 10.1136/heartjnl-2020-317685.
    PubMed     Abstract available
    
    
    
96. NIJJER SS, Petraco R, Sen S
    Optimal management of acute coronary syndromes in the era of COVID-19.
    Heart. 2020;106:1609-1616.
    PubMed    
    
    
    August 2020
97. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available
    
    
    July 2020
98. WILLIAMS C, Brown DL
    Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease.
    Heart. 2020 Jul 21. pii: heartjnl-2019-316432. doi: 10.1136/heartjnl-2019-316432
    PubMed     Abstract available
    
    
    June 2020
99. NAZIR MS, Mittal TK, Weir-McCall J, Nieman K, et al
    Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice.
    Heart. 2020 Jun 19. pii: heartjnl-2019-315607. doi: 10.1136/heartjnl-2019-315607
    PubMed     Abstract available
    
    
    
100. HOOLE SP, Bambrough P
     Recent advances in percutaneous coronary intervention.
     Heart. 2020 Jun 10. pii: heartjnl-2019-315707. doi: 10.1136/heartjnl-2019-315707
     PubMed     Abstract available
     
     
     
101. BRIDGMAN PG
     The comorbid patient: does your heart sink?
     Heart. 2020;106:790.
     PubMed    
     
     
     
102. ALKHALIL M, Spence MS, Owens C
     Ischaemic changes during transcatheter aortic valve implantation.
     Heart. 2020;106:801-866.
     PubMed    
     
     
     
103. CROWE F, Zemedikun DT, Okoth K, Adderley NJ, et al
     Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.
     Heart. 2020;106:810-816.
     PubMed     Abstract available
     
     
     May 2020
104. KEULARDS DCJ, Fournier S, van 't Veer M, Colaiori I, et al
     Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement.
     Heart. 2020 May 29. pii: heartjnl-2020-316689. doi: 10.1136/heartjnl-2020-316689
     PubMed     Abstract available
     
     
     
105. VAGO H, Szabo L, Dohy Z, Czimbalmos C, et al
     Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries.
     Heart. 2020 May 23. pii: heartjnl-2019-316295. doi: 10.1136/heartjnl-2019-316295
     PubMed     Abstract available
     
     
     
106. AHMADVAZIR S, Pradhan J, Khattar RS, Senior R, et al
     Sex-based impact of carotid plaque in patients with chest pain undergoing stress echocardiography.
     Heart. 2020 May 22. pii: heartjnl-2019-316507. doi: 10.1136/heartjnl-2019-316507
     PubMed     Abstract available
     
     
     
107. KOO CY, Aung AT, Chen Z, Kristanto W, et al
     Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
     Heart. 2020 May 18. pii: heartjnl-2019-316118. doi: 10.1136/heartjnl-2019-316118
     PubMed     Abstract available
     
     
     
108. BURDEN AF
     Tub bathing and heart disease.
     Heart. 2020;106:710.
     PubMed    
     
     
     
109. NEUMANN JT, Twerenbold R
     How do comorbidities influence troponin concentrations?
     Heart. 2020;106:634-635.
     PubMed    
     
     
     
110. BING R, Mitchell AJ, Newby DE
     Chest pain: when in doubt....
     Heart. 2020;106:690-706.
     PubMed    
     
     
     April 2020
111. ADAMSON PD, Mills NL, Newby DE, Troughton RW, et al
     Response to: 'Convalescent troponin and cardiovascular death following acute coronary syndrome' by Kawada.
     Heart. 2020;106:545-546.
     PubMed    
     
     
     
112. KAWADA T
     Convalescent troponin and cardiovascular death in patients with acute coronary syndrome.
     Heart. 2020;106:545.
     PubMed    
     
     
     
113. GALLACHER PJ, Shah ASV
     Walking the tightrope: cardiovascular risk prediction in patients after acute coronary syndrome.
     Heart. 2020;106:484-486.
     PubMed    
     
     
     
114. MEHILLI J, Presbitero P
     Coronary artery disease and acute coronary syndrome in women.
     Heart. 2020;106:487-492.
     PubMed     Abstract available
     
     
     
115. POPPE KK, Doughty RN, Wells S, Wu B, et al
     Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome.
     Heart. 2020;106:506-511.
     PubMed     Abstract available
     
     
     
116. PARKINSON J, Minton J, Bouttell J, Lewsey J, et al
     Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?
     Heart. 2020;106:584-589.
     PubMed     Abstract available
     
     
     March 2020
117. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
     Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
     Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
     PubMed     Abstract available
     
     
     
118. WALD DS, Casey-Gillman O, Comer K, Mansell JS, et al
     Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative.
     Heart. 2020 Mar 10. pii: heartjnl-2019-316227. doi: 10.1136/heartjnl-2019-316227
     PubMed     Abstract available
     
     
     
119. ARNOLD SV
     Can we improve the appropriateness of PCI?
     Heart. 2020;106:405-406.
     PubMed    
     
     
     
120. FORD TJ, Berry C
     Angina: contemporary diagnosis and management.
     Heart. 2020;106:387-398.
     PubMed    
     
     
     
121. MOSS AJ, Jordan A, Carpenter JP
     Seventy-one-year-old man with transient left bundle branch block.
     Heart. 2020;106:386-398.
     PubMed    
     
     
     
122. CAULDWELL M, Steer PJ, von Klemperer K, Kaler M, et al
     Maternal and neonatal outcomes in women with history of coronary artery disease.
     Heart. 2020;106:380-386.
     PubMed     Abstract available
     
     
     February 2020
123. IHDAYHID AR, Sapontis J
     The fractional flow reserve grey zone: a blueprint for the future of coronary revascularisation.
     Heart. 2020 Feb 29. pii: heartjnl-2019-316435. doi: 10.1136/heartjnl-2019-316435
     PubMed    
     
     
     
124. HENNIGAN B, Berry C, Collison D, Corcoran D, et al
     Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
     Heart. 2020 Feb 29. pii: heartjnl-2019-316075. doi: 10.1136/heartjnl-2019-316075
     PubMed     Abstract available
     
     
     
125. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
     P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
     Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
     PubMed     Abstract available
     
     
     
126. MARIATHAS M, Curzen N
     Use of troponins in clinical practice: Evidence against the use of troponins in clinical practice.
     Heart. 2020;106:251-252.
     PubMed    
     
     
     
127. COLLINSON PO, Apple F, Jaffe AS
     Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice.
     Heart. 2020;106:253-255.
     PubMed    
     
     
     
128. LITWIN SE, Coles A, Hill CL, Alhanti B, et al
     Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.
     Heart. 2020;106:273-279.
     PubMed     Abstract available
     
     
     
129. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
     Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
     Heart. 2020;106:248-250.
     PubMed    
     
     
     December 2019
130. YANG JX, Stevenson MJ, Valsdottir L, Ho K, et al
     Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.
     Heart. 2019 Dec 19. pii: heartjnl-2019-315835. doi: 10.1136/heartjnl-2019-315835
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: